임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
리드: 셀트리온
- 1상완료· Healthy SubjectsPK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
리드: 대웅제약
- 1상완료· Healthy Male AdultsTo Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
리드: JW중외제약
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
리드: 셀트리온
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects
리드: 셀트리온
- 1상완료· Healthy VolunteersBioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers
리드: 유한양행
- 1상완료· Healthy SubjectsA Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
리드: 종근당
- 1상완료· Healthy VolunteersBioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers
리드: 유한양행
- 1상완료· Healthy VolunteersBioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers
리드: 유한양행
- 1상완료· Type 2 Diabetes MellitusClinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.
리드: 종근당
- 1상완료· Healthy Male SubjectsTo Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects
리드: 셀트리온
- 1상완료· HypertensionA Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)
리드: 종근당
- 1상완료· Glabellar LinesEvaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
- 1상완료· Type 2 Diabetes MellitusA Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
리드: 종근당
- 1상완료· Benign Prostate Hypertrophy(BPH)A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
리드: 종근당
- 1상완료· DyslipidemiasA Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
리드: 종근당
- 1상완료· HealthyTo Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers
리드: JW중외제약
- 1상완료· Allergic DiseaseA Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases
리드: 유한양행
- 1상완료· Hypertension and DyslipidemiaA Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
리드: 종근당
- 1상완료· HypertensionA Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg
리드: 종근당
- 1상완료· Essential HypertensionA Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers
리드: 셀트리온
- 1상완료· Hypertension and DyslipidemiaA Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
리드: 종근당
- 1상완료· Type II DiabetesA Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
리드: 종근당
- 1상완료· Healthy VolunteersA Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
리드: 한미약품
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.